IRIS
PARODI, BRUNELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.382
Totale 10.382
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.382
Totale 10.382
Salva come PNG Salva come JPEG
Città #
Genova 7.914
Rapallo 1.265
Genoa 1.177
Bordighera 24
Vado Ligure 2
Totale 10.382
Salva come PNG Salva come JPEG
Nome #
A focus on mucoadhesive polymers and their application in buccal dosage forms 147
Green extraction from pomegranate marcs for the production of functional foods and cosmetics 142
Chitosan-clodronate nanoparticles loaded in poloxamer gel for intra-articular administration 140
Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin in solution and in the solid state 136
Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino)ethyl 4-amino-benzoate, N4]-chlorideplatinum (II) monohydrochloride monohydrate 130
PREPARATION, CHARACTERIZATION AND IN VITRO ANTIVIRAL ACTIVITY EVALUATION OF FOSCARNET-CHITOSAN NANOPARTICLES 130
Microspheres containing carnosic acid for the treatment of basil fungal diseases 126
From pomegranate marcs to a potential bioactive ingredient: a recycling proposal for pomegranate squeezing marcs 126
Complex extemporaneous preparations: stability study of a formulation containing diethylpropion hydrochloride in hard capsules 125
An example of application of a mixture design with constraints to a pharmaceutical formulation 124
Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy. 124
An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose 123
Buccoadhesive oxycodone hydrochloride disks: plasma pharmacokinetics in healthy volunteers and clinical study 120
Study of retinoic acid polymorphism 119
STABILITY INDICATING HPLC ASSAY FOR RETINOIC ACID IN HARD GELATINE CAPSULES CONTAINING LACTOSE AND AS BULK DRUG SUBSTANCE 117
Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride 117
Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice. 116
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 113
Median-based robust regression methods in prediction of drug stability 113
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation 112
Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery 111
Somatostatin release from rat cerebral cortex synaptosomes 111
Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR. 110
Development, characterization and preliminary clinical evaluation of mucoadhesive vaginal gels containing chlorhexidine digluconate 108
Compound from Cupuliferae .15. Flavonoid Glycosides from Quercus-Canariensis Willd 105
Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments 105
A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraacetic acid useful for the localizationof radionuclides for diagnostic and therapeutic purposes (EP domanda) 105
Stability study of hard gelatin capsules containing retinoic acid 104
A Method for the production of bioadhesive compact matrices (European Patent) 104
"A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid useful for the localization of radionuclides for diagnostic and therapeutic purpose" (PCT deposito) 102
A new carrier for cisplatin: nanoparticles deriving from the interaction between N-trimethyl glycol chitosan and poly-L-glutamate 101
Phytotoxic activity of Salvia x jamensis 99
Blood and synovial levels of piroxicam and their effects on some metabolites of arachidonic acid 99
Cisplatin Combined with the new Cisplatin-Procaine Complex DPR : In Vitro and In Vivo Studies 99
Buccoadhesive polymeric films for oromucosal oxycodone delivery in acute pain control 98
A new conjugate of human albumin and p-SCN-Bn-DOTA for radioguided occult lesion localization in breast cancer (ROLL). 97
Flavonoid Glycosides from Quercus-Pubescens-Willd., Quercus-Cerris L. and Quercus-Ilex L.. 96
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 96
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex 95
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (US Patent) 95
Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan 94
Cisplatin delivery: a study on a cisplatin-hyaluronate complex and nanoparticles formed by its interaction with N-trimethyl chitosan 94
A method for the production of bioadhesive compact matrices (Japanese Patent) 94
Preparation and characterization of PLGA nanoparticles containing demethylfruticulin A from Salvia corrugata Vahl. (Lamiaceae) 92
A Chitosan-Poloxamer 407 Matrix for Buccal Drug Delivery. 91
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED 91
Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane 91
Identificazione di nuovi prodotti di degradazione dell'ibuprofene. 90
A Hydrophilic Matrix Generated by Direct Compression and Thermal Treatment: Application in Press-Coating 90
Characterisation and in vitro evaluation of biological activity of retinoic acid complexes with some bile salts 90
Metodo di produzione di matrici compatte bioadesive impiegabili come tali o per il rilascio controllato di sostanze attive e matrici compatte così ottenute. 89
A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation 89
Chitosan-Alginate Nanoparticles Containing Cisplatin Complexed With Alginate 87
Cytotoxicity and Cellular Accumulation of a New Cis-Diammineplatinum (II) Complex Containing Procaine in Murine L 1210 Cells Sensitive and Resistant to Cis-Diammine dicholoropatinum(II) 87
A New Hydrophilic Bioadhesive Matrix for Controlled Drug Release Generated in Direct Compression Tablets by Thermal Treatment: Mechanism Elucidation 86
Preparation of ellagic acid micro and nano formulations with amazingly increased water solubility by its entrapment in pectin or non-PAMAM dendrimers suitable for clinical applications 85
Preparation and evaluation of N-trimethyl chitosan/alginate nanoparticles containing cisplatin complexed with alginate 84
PROCEDE POUR LA FABRICATION DE MATRICES COMPACTES BIOADHESIVES QUI PEUVENT ETRE UTILISEES SOIT EN TANT QUE TELLES, SOIT POUR LA LIBERATION PROLONGEE DE SUBSTANCES ACTIVES ET MATRICES COMPACTES AINSI OBTENUES A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED (Canadian Patent) 84
Evaluation of a new matrix obtained by direct compression and thermal treatment in tablet press-coating 83
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (생체접착성 컴팩트 매트릭스의 제조방법) 82
Modification of Drug Release from Tablets Produced By direct compression 81
An alternative route of administration of oxycodone:pharmacokinetics and clinical development in cancer pain control 81
Preliminary studies on the implementation of polymeric nanoparticles containing clodronate. 81
Solubilization study of retinoic acid employing some bile salts 81
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 80
Nanoparticles Formed by Interaction of Poly-L-Lysine or Chitosan With Polycarboxylic Polymers Complexed with Cisplatin 79
Chemical and biological properties of a new Cis- diammineplatinum(II) complex containing para-aminobenzoic acid as amino ligand 79
A Method for the production of bioadhesive compact matrices (Russian Patent) 79
Preformulative study of liposomes containing retinoic acid 78
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (China Patent) 78
A novel nanoparticulate system based on a new cisplatin-hyaluronate complex and N-trimethyl chitosan 77
Stabilization studies of chitosan/foscarnet nanoparticles by coating with Poloxamer 407 or glutaraldeyde cross-linking 76
Applicazione del metodo di regressione robusta MBWR nella previsione di shelf life: stabilità di capsule contenenti acido retinoico. 75
A Method for the production of bioadhesive compact matrices 75
Herbal Mixtures with Claimed Slimming Activity - Determination by TLC and HPLC of Illegally Added Drugs 73
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery Film polimerici mucoadesivi e sistemi a riserva per il rilascio transmucosale di farmaco 73
Pharmacokinetics of piroxicam in rheumatoid arthritis:relationship between plasma and synovial levels. 72
Preparation and Characterization of Brushite-Based Bone Cement 72
Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia 71
LONGROLL: a new human albumin conjugate for radioguided localization of non-palpable breast cancer lesion 71
Aspetti preliminari di uno studio preformulativo riguardante l'acido retinoico. 70
Mucoadesive polymeric films and reservoir devices for transmucosal drug delivery. 70
Gel di fibrina contenenti un complesso cisplatino-ialuronato o nanoparticelle polimeriche da esso derivate per la terapia tumorale locale 70
Cis-Diamminedichloroplatinum (II) - Procaine Pharmacokinetic Interaction in Mice Bearing P388 Leukemia 69
A water-soluble 1,2-diaminocyclohexaneplatinum(II) complex containing procaine hydrochloride: synthesis and antiproliferative activity in vitro 68
SERUM, URINE AND PERITONEAL FLUID LEVELS OF 5-FU FOLLOWING IP ADMINISTRATION. 68
Optimization of a parenteral thermoresponsive formulation based on metformin hydrochloride 67
Preparation and characterization of foscarnet/chitosan nanoparticles 66
RESORBABLE BRUSHITE BONE CEMENT WITH CONTROLLED DRUG-RELEASING CAPABILITIES 66
FUNCTIONAL INTERACTIONS BETWEEN ALL TRANS RETINOIC ACID AND BILE SALTS ON CELL PROLIFERATION. 65
Amazing increase of Ellagic Acid solubility by its entrapping into not PAMAM-structured biocompatible dendrimer scaffolds 64
Complessazione dell’acido retinoico mediante sali di acidi biliari: caratterizzazione chimico-fisica e valutazione dell’efficacia antiproliferativa su colture cellulari 63
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery 63
Rivestimento con film polimerici di forme di dosaggio buccoadesive 62
An experience in mucoadhesive drug delivery 62
Formulazione bioadesiva per somministrazione boccale di Ossicodone cloridrato 61
Development of gel formulations for localized release of metformin 61
Valutazione preliminare dell'applicabilità del metodo statistico di regressione robusta LMS alla previsione di stabilità 60
Valutazione dell'uso dei compatti di mucina come substrato negli screening preformulativi di mucoadesività 60
"Valutazione in vitro della bioadesività di forme di dosaggio boccali" 60
Totale 9.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.574
article - articoli 14.203
book - libri 0
conference - conferenze 10.516
curatela - curatele 0
other - altro 0
patent - brevetti 2.855
selected - selezionate 0
volume - volumi 0
Totale 55.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.644 109 54 154 115 192 283 395 99 184 554 394 111
2020/2021468 29 27 29 31 18 51 16 36 60 56 62 53
2021/20221.460 23 133 95 196 41 75 91 363 54 129 66 194
2022/20231.534 160 104 14 204 221 287 4 114 280 10 120 16
2023/2024819 37 101 19 107 51 251 43 31 39 21 46 73
2024/2025117 117 0 0 0 0 0 0 0 0 0 0 0
Totale 10.535